Intelligence / Healthtech / Health Funding Register / Savannah Therapeutics, Inc
Fundingraised $3.9M11 Sept 2026
Savannah Therapeutics, Inc
11 Sept 2026: Raised $3.9M · Riverdale, MD. Recorded in the SEC Form D data sets.
- Filed
- 11 Sept 2026
- Location
- Riverdale, MD
- State
- Maryland
- Industry
- Other Health Care
- Amount raised
- $3.9M
- Offering size
- $6.0M
- Revenue range
- No Revenues
- Year of incorporation
- 2026
- Entity type
- Corporation
- Jurisdiction
- Delaware
- First sale
- 2026-04-17
- Securities
- Debt
- Investors so far
- 28
- SEC CIK
- 0002149298
What this signal means
Companies buy in the months after they raise: new hires, new vendors, new markets.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
Reach them with AOS
Find the decision makers at Savannah Therapeutics, Inc
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.
More from Maryland
Health Funding Register
24 SeptAromha, Inc.raised $75K · Potomac, MDFunding24 SeptSeraxis Holdings, Inc.raised $10.0M · Germantown, MDFunding23 SeptUvantis Therapeutics, Inc.raised $100K · Columbia, MDFunding21 SeptFunctional Longevity Labs, Inc.raised $25K · Easton, MDFunding21 SeptMonocacy Therapeutics Inc.raised $49 · Monrovia, MDFunding16 SeptTerrace Systems, Inc.raised $250K · Silver Spring, MDFunding
Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.